BAIXERAS E ET AL: "CHARACTERIZATION OF THE LYMPHOCYTE ACTIVATION GENE 3-ENCODED PROTEIN. A NEW LIGAND FOR HUMAN LEUKOCYTE ANTIGEN CLASS II ANTIGENS", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 176, 1 August 1992 (1992-08-01), pages 327-337, XP000672152, ISSN: 0022-1007, DOI: 10.1084/JEM.176.2.327 (B1)

WO-A2-95/30750 (B1)

KOCAK E ET AL: "Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 66, no. 14, 15 July 2006 (2006-07-15) , pages 7276-7284, XP002488612, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-05-2128 (B1)

MACON-LEMAITRE L ET AL: "The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells", IMMUNOLOGY, BLACKWELL PUBLISHING, OXFORD, GB, vol. 115, no. 2, 1 June 2005 (2005-06-01), pages 170-178, XP002453818, ISSN: 0019-2805, DOI: 10.1111/J.1365-2567.2005.02145.X (B1)

SHAWN D BLACKBURN ET AL: "Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection", NATURE IMMUNOLOGY, vol. 10, no. 1, 30 November 2008 (2008-11-30), pages 29-37, XP055047746, ISSN: 1529-2908, DOI: 10.1038/ni.1679 (B1)

SUBRAMANYAM ET AL.: 'Soluble human lymphocyte activation gene-3 modulates allospecific T cell responses.' INT. IMMUNOL. vol. 10, no. 5, May 1998, pages 679 - 689, XP002291778 (B1)

TRIEBEL F: "LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination", TRENDS IN IMMUNOLOGY, ELSEVIER, RAHWAY, NJ, US, vol. 24, no. 12, 1 December 2003 (2003-12-01), pages 619-622, XP004476041, ISSN: 1471-4906, DOI: 10.1016/J.IT.2003.10.001 (B1)

US-A- 6 143 273 (B1)

US-A1- 2002 086 014 (B1)

US-A1- 2002 146 753 (B1)

US-A1- 2003 059 937 (B1)

US-A1- 2003 129 601 (B1)

US-A1- 2004 072 164 (B1)

US-A1- 2005 009 136 (B1)

US-A1- 2005 226 876 (B1)

US-A1- 2006 177 442 (B1)

US-A1- 2006 240 024 (B1)

US-A1- 2007 004 910 (B1)

US-A1- 2007 160 598 (B1)

US-A1- 2008 069 822 (B1)

US-B1- 6 197 524 (B1)

WO-A-91/10682 (B1)

WO-A1-2006/007850 (B1)

WO-A1-2008/007648 (B1)

WO-A1-2008/132601 (B1)

WO-A1-97/03695 (B1)

WO-A2-00/69914 (B1)

WO-A2-2005/034733 (B1)

DRAKE C G ET AL: "Blocking the regulatory T cell molecule LAG-3 augments in vivo anti-tumor immunity in an autochthonous model of prostate cancer", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 24, no. 18, suppl, 20 June 2006 (2006-06-20), page 2573, XP009138507, ISSN: 0732-183X (B1)